Buried deep within the dazzlingly intricate machinery of the human cell could lie a key to treating a range of deadly cancers, according to a team of scientists at Florida State University.
Cell & Microbiology
Feb 26, 2019
0
96
A new compound based on Iridium, a rare metal which landed in the Gulf of Mexico 66 M years ago, hooked onto albumin, a protein in blood, can attack the nucleus of cancerous cells when switched on by light, University of ...
Biochemistry
Feb 04, 2019
5
584
CERN, home of the 27-kilometre Large Hadron Collider (LHC), is developing a new particle accelerator just two metres long.
General Physics
Jul 28, 2015
0
45
The dynamic field of medical laser applications continually offers new systems and techniques enabling less invasive or more targeted treatments. But the path from the lab to the clinic can be slowed by "a multiplicity of ...
Optics & Photonics
Jun 17, 2015
0
41
Biomolecular 'nanocarriers' formed by the careful assembly of protein subunits are common in nature and perform a range of essential roles in biological processes, powered by the biological energy carrier adenosine-5'-triphosphate ...
Biochemistry
Aug 09, 2013
0
0
(Phys.org) —Researchers have developed a concept to potentially improve delivery of drugs for cancer treatment using nanoparticles that concentrate and expand in the presence of higher acidity found in tumor cells.
Bio & Medicine
Jul 10, 2013
0
0
Scientists from CIC bioGUNE and the Laboratoire de Chimie des Polymères Organiques (LCPO) in Bordeaux have jointly undertaken a project to develop "smart" nanoparticles. These polymeric particles act as "nanomissiles" against ...
Bio & Medicine
Jun 13, 2013
0
0
Scientists working at the Institut Laue-Langevin have shown that the charge of gold nanoparticles, identified by major pharmaceutical companies as a drug delivery agent of the future for the treatment of cancer, affects how ...
Bio & Medicine
Jun 07, 2013
0
1
Biologists at Heidelberg University have discovered new approaches for the treatment of cancer. They investigated how a special signalling molecule, the epidermal growth factor (EGF), stimulates the separation of chromosomes ...
Cell & Microbiology
May 14, 2013
0
0
Scientists at the Walter and Eliza Hall Institute and their collaborators have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients.
Biochemistry
Apr 21, 2013
0
0
